CAM
ABBV icon

Cresset Asset Management’s AbbVie ABBV Stock Holding History

Cresset Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Hold
0
– -$17.8K – 1714
2024
Q4 		– Sell
-100
Closed -$18.4K – 1716
2024
Q3 		$19.7K Hold
100
– – ﹤0.01% 2134
2024
Q2 		$17.2K Buy
+100
New +$16.6K ﹤0.01% 2059

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cresset Asset Management's ABBV Position: Q1 2026 in Review

Cresset Asset Management reduced its AbbVie (ABBV) stake by 1% in Q1 2026, selling an estimated $408K and leaving 181,586 shares worth $39.5M. The position accounts for 0.17% of the portfolio, ranked #90.

Cresset Asset Management first reported a position in ABBV in Q4 2018 and has held it in 30 quarters since. The position peaked at $67.7M in Q3 2024. 4,087 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Cresset Asset Management held 181,586 shares of AbbVie worth $39.5M as of Q1 2026.
  • Cresset Asset Management sold 1,839 AbbVie shares in Q1 2026, an estimated $408K.
  • AbbVie made up 0.17% of Cresset Asset Management's portfolio in Q1 2026, its #90 holding.
  • Cresset Asset Management first reported a position in AbbVie in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's AbbVie position peaked at $67.7M in Q3 2024.
  • 4,087 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.